301 related articles for article (PubMed ID: 8661813)
1. Gastric carcinoids and neuroendocrine carcinomas: pathogenesis, pathology, and behavior.
Rindi G; Bordi C; Rappel S; La Rosa S; Stolte M; Solcia E
World J Surg; 1996 Feb; 20(2):168-72. PubMed ID: 8661813
[TBL] [Abstract][Full Text] [Related]
2. A prospective study of gastric carcinoids and enterochromaffin-like cell changes in multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: identification of risk factors.
Berna MJ; Annibale B; Marignani M; Luong TV; Corleto V; Pace A; Ito T; Liewehr D; Venzon DJ; Delle Fave G; Bordi C; Jensen RT
J Clin Endocrinol Metab; 2008 May; 93(5):1582-91. PubMed ID: 18270260
[TBL] [Abstract][Full Text] [Related]
3. Management of carcinoid tumors of the stomach, duodenum, and pancreas.
Akerström G
World J Surg; 1996 Feb; 20(2):173-82. PubMed ID: 8661814
[TBL] [Abstract][Full Text] [Related]
4. Regression of type II gastric carcinoids in multiple endocrine neoplasia type 1 patients with Zollinger-Ellison syndrome after surgical excision of all gastrinomas.
Richards ML; Gauger P; Thompson NW; Giordano TJ
World J Surg; 2004 Jul; 28(7):652-8. PubMed ID: 15383867
[TBL] [Abstract][Full Text] [Related]
5. The antral mucosa as a new site for endocrine tumors in multiple endocrine neoplasia type 1 and Zollinger-Ellison syndromes.
Bordi C; Corleto VD; Azzoni C; Pizzi S; Ferraro G; Gibril F; Delle Fave G; Jensen RT
J Clin Endocrinol Metab; 2001 May; 86(5):2236-42. PubMed ID: 11344233
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic aspects of gastric neuroendocrine tumors.
Rindi G
Am J Surg Pathol; 1995; 19 Suppl 1():S20-9. PubMed ID: 7762736
[TBL] [Abstract][Full Text] [Related]
7. Carcinoid tumors of the stomach: a clinical and radiographic study.
Binstock AJ; Johnson CD; Stephens DH; Lloyd RV; Fletcher JG
AJR Am J Roentgenol; 2001 Apr; 176(4):947-51. PubMed ID: 11264084
[TBL] [Abstract][Full Text] [Related]
8. Argyrophil cell hyperplasia and a carcinoid tumour in the stomach of a patient with sporadic Zollinger-Ellison syndrome.
Feurle GE
Gut; 1994 Feb; 35(2):275-7. PubMed ID: 8307483
[TBL] [Abstract][Full Text] [Related]
9. The multiple endocrine neoplasia type I gene locus is involved in the pathogenesis of type II gastric carcinoids.
Debelenko LV; Emmert-Buck MR; Zhuang Z; Epshteyn E; Moskaluk CA; Jensen RT; Liotta LA; Lubensky IA
Gastroenterology; 1997 Sep; 113(3):773-81. PubMed ID: 9287968
[TBL] [Abstract][Full Text] [Related]
10. [Gastric carcinoid--pathogenesis and treatment].
Bründler R; Gebbers JO; Criblez D
Schweiz Med Wochenschr; 1999 Jun; 129(25):945-50. PubMed ID: 10422189
[TBL] [Abstract][Full Text] [Related]
11. Gastric carcinoid tumors: the biology and therapy of an enigmatic and controversial lesion.
Gilligan CJ; Lawton GP; Tang LH; West AB; Modlin IM
Am J Gastroenterol; 1995 Mar; 90(3):338-52. PubMed ID: 7872269
[TBL] [Abstract][Full Text] [Related]
12. Expression of vesicular monoamine transporters in endocrine hyperplasia and endocrine tumors of the oxyntic stomach.
Eissele R; Anlauf M; Schäfer MK; Eiden LE; Arnold R; Weihe E
Digestion; 1999; 60(5):428-39. PubMed ID: 10473967
[TBL] [Abstract][Full Text] [Related]
13. Hypergastrinemia and gastric enterochromaffin-like cells.
Bordi C; D'Adda T; Azzoni C; Pilato FP; Caruana P
Am J Surg Pathol; 1995; 19 Suppl 1():S8-19. PubMed ID: 7762739
[TBL] [Abstract][Full Text] [Related]
14. Gastric argyrophil carcinoidosis in patients with Zollinger-Ellison syndrome due to type 1 multiple endocrine neoplasia. A newly recognized association.
Solcia E; Capella C; Fiocca R; Rindi G; Rosai J
Am J Surg Pathol; 1990 Jun; 14(6):503-13. PubMed ID: 1970928
[TBL] [Abstract][Full Text] [Related]
15. Aggressive forms of gastric neuroendocrine tumors in multiple endocrine neoplasia type I.
Bordi C; Falchetti A; Azzoni C; D'Adda T; Canavese G; Guariglia A; Santini D; Tomassetti P; Brandi ML
Am J Surg Pathol; 1997 Sep; 21(9):1075-82. PubMed ID: 9298884
[TBL] [Abstract][Full Text] [Related]
16. Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: a clinicopathologic study.
Rindi G; Luinetti O; Cornaggia M; Capella C; Solcia E
Gastroenterology; 1993 Apr; 104(4):994-1006. PubMed ID: 7681798
[TBL] [Abstract][Full Text] [Related]
17. Involvement of BCL-2 oncoprotein in the development of enterochromaffin-like cell gastric carcinoids.
Azzoni C; Doglioni C; Viale G; Delle Fave G; De Boni M; Caruana P; Ferraro G; Bordi C
Am J Surg Pathol; 1996 Apr; 20(4):433-41. PubMed ID: 8604810
[TBL] [Abstract][Full Text] [Related]
18. [Neuroendocrine tumors of the stomach. Pathogenesis, classification and clinical aspects].
Bordi C; Azzoni C; D'Adda T; Caruana P; Carlinfante G
Pathologe; 1997 Jul; 18(4):313-21. PubMed ID: 9380606
[TBL] [Abstract][Full Text] [Related]
19. Pathogenesis of ECL cell tumors in humans.
Bordi C; D'Adda T; Azzoni C; Ferraro G
Yale J Biol Med; 1998; 71(3-4):273-84. PubMed ID: 10461358
[TBL] [Abstract][Full Text] [Related]
20. Progression of gastric enterochromaffin-like cells growth in Zollinger-Ellison syndrome and atrophic body gastritis patients.
Delle Fave G; Marignani M; Corleto VD; Angeletti S; D'Ambra G; Ferraro G; D'Adda T; Azzoni C; Jensen RT; Annibale B; Bordi C
Dig Liver Dis; 2002 Apr; 34(4):270-8. PubMed ID: 12038811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]